Lubec G, Ratzenhofer E
Nephron. 1979;24(2):93-5. doi: 10.1159/000181692.
Collagenolytic activity of rat kidney with glomerulonephritis (GN) of Masugi's type was determined by a series of biological experiments. The determination was carried out during the heterologous phase of the disease together with inhibition studies in vivo and in vitro. Erythromycin has been tested in vivo for its inhibitory activity and an activity of collagenase was found in untreated rats with GN only, the panel treated with erythromycin did not show any collagenolysis. Statistical calculations indicate the significance of the inhibition (p less than 0.001). In addition, kidneys of test animals with GN have been investigated for their enzymatic activity and the inhibition by erythromycin in vitro where the kidneys failed to show collagenolytic activity. It can be concluded that erythromycin is able to inhibit in vivo and in vitro the activity of the collagenolytic enzyme produced by polymorphonuclear leukocytes during the heterologous phase of the nephritis, an effect which leads to the recovery of the physiological equilibrium of the protease and its inhibitor.
通过一系列生物学实验测定了患真珠状肾小球肾炎(GN)大鼠肾脏的胶原酶活性。在疾病的异源期进行了测定,并同时进行了体内和体外抑制研究。对红霉素进行了体内抑制活性测试,发现仅在未治疗的患GN大鼠中存在胶原酶活性,用红霉素治疗的组未显示任何胶原分解作用。统计计算表明抑制作用具有显著性(p小于0.001)。此外,对患GN实验动物的肾脏进行了酶活性及红霉素体外抑制作用研究,结果显示肾脏未表现出胶原分解活性。可以得出结论,红霉素能够在体内和体外抑制肾炎异源期多形核白细胞产生的胶原分解酶的活性,这一作用导致蛋白酶及其抑制剂的生理平衡得以恢复。